First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia Our study demonstrated that ...
Listed mortgage company RHG, formally RAMS Mortgage Corp, has engaged with suitor Resimac and opened the door to a period of due diligence on the $128 million proposal. RHG has executed ...
On Monday, RHG directors announced they had agreed to accept the latest bid of 48 cents per share as well as a three-cent-per share dividend, with total payments of 51 cents per share. The total puts ...
Pepper, which typically provides low-doc loans, yesterday unveiled an offer of 46c a share for RHG, which it claimed was "superior" to a bid by rival non-bank Resimac and dealmaker Trevor Loewensohn.
RHG owns the closed mortgage book of the former RAMS Home Loans Group. RAMS sold its brand and distribution business and all the business it wrote from November 15 to Westpac Banking Corporation last ...
Non-bank lender Resimac has made a bid to acquire the remnants of mortgage firm RAMS in a joint proposal with former Babcock & Brown banker Trevor Loewensohn. The conditional proposal values the ...
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia We conducted a phase II, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results